Vivani Medical (VANI) Cash from Operations (2014 - 2026)
Vivani Medical (VANI) posted quarterly Cash from Operations of 6196000.0 for Q1 2026, down 20.01% year-over-year from 7745750.12 in Q1 2025, and up 7.78% quarter-over-quarter from 6719000.0 in Q4 2025.
Vivani Medical (VANI) Cash from Operations (2014 - 2026) Analysis & Trends
Vivani Medical's Cash from Operations history runs 13 years deep, the most recent figure standing at 6196000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 20.01% year-over-year to 6196000.0; the TTM figure through Mar 2026 stood at 25353000.0 (down 18.27% YoY), while the FY2025 annual figure was 24320000.0, down 17.0% from the prior year.
- Cash from Operations for Q1 2026 stood at 6196000.0, up from 6719000.0 in the prior quarter.
- The five-year high for Cash from Operations was 3176000.0 in Q1 2022, with the low at 7702000.0 in Q3 2023.
- The 5-year median for Cash from Operations is 5661000.0 (2024), against an average of 5516941.18.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations tumbled 308.23% in 2022, then jumped 35.23% in 2024.
- Vivani Medical's Cash from Operations stood at 5203000.0 in 2022, then surged by 33.1% to 3481000.0 in 2023, then tumbled by 66.96% to 5812000.0 in 2024, then slipped by 15.61% to 6719000.0 in 2025, then rose by 7.78% to 6196000.0 in 2026.
- Business Quant data shows VANI's Cash from Operations at 6196000.0 in Q1 2026, 6719000.0 in Q4 2025, and 6351000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -6.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.04 Mn |
| Jun 30, 2026 | -6.04 Mn |
| Mar 31, 2026 | -6.20 Mn |
| Mar 31, 2026 | -6.20 Mn |
| Dec 31, 2025 | -6.72 Mn |
| Dec 31, 2025 | -6.72 Mn |
| Sep 30, 2025 | -6.35 Mn |
| Sep 30, 2025 | -6.35 Mn |
| Jun 30, 2025 | -6.09 Mn |
| Jun 30, 2025 | -6.09 Mn |
| Mar 31, 2025 | -5.16 Mn |
| Mar 31, 2025 | -5.16 Mn |
| Dec 31, 2024 | -5.81 Mn |
| Dec 31, 2024 | -5.81 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Jun 30, 2024 | -4.80 Mn |
| Jun 30, 2024 | -4.80 Mn |
| Mar 31, 2024 | -4.51 Mn |
| Mar 31, 2024 | -4.51 Mn |